Interviews with Key Healthcare Opinion Leaders - Episode #103
Dr. Andrew Hertler explains the FDA’s decision to narrow approvals for PD-1 inhibitors for stomach and esophageal cancers
Advertisement

Expert Interviews

Urban Health Weekly

Featured Knowledge Hubs

AI in Medicine

Network Websites

Powered by DocWire News